1. Home
  2. ATAI vs RWAY Comparison

ATAI vs RWAY Comparison

Compare ATAI & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • RWAY
  • Stock Information
  • Founded
  • ATAI 2018
  • RWAY 2015
  • Country
  • ATAI Germany
  • RWAY United States
  • Employees
  • ATAI N/A
  • RWAY N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • RWAY
  • Sector
  • ATAI Health Care
  • RWAY
  • Exchange
  • ATAI Nasdaq
  • RWAY Nasdaq
  • Market Cap
  • ATAI 444.7M
  • RWAY 410.4M
  • IPO Year
  • ATAI 2021
  • RWAY 2021
  • Fundamental
  • Price
  • ATAI $4.57
  • RWAY $10.67
  • Analyst Decision
  • ATAI Strong Buy
  • RWAY Buy
  • Analyst Count
  • ATAI 3
  • RWAY 6
  • Target Price
  • ATAI $13.33
  • RWAY $11.00
  • AVG Volume (30 Days)
  • ATAI 6.3M
  • RWAY 251.4K
  • Earning Date
  • ATAI 08-14-2025
  • RWAY 08-07-2025
  • Dividend Yield
  • ATAI N/A
  • RWAY 13.12%
  • EPS Growth
  • ATAI N/A
  • RWAY 153.06
  • EPS
  • ATAI N/A
  • RWAY 1.91
  • Revenue
  • ATAI $2,309,000.00
  • RWAY $140,975,000.00
  • Revenue This Year
  • ATAI $423.05
  • RWAY N/A
  • Revenue Next Year
  • ATAI N/A
  • RWAY N/A
  • P/E Ratio
  • ATAI N/A
  • RWAY $5.57
  • Revenue Growth
  • ATAI 510.85
  • RWAY N/A
  • 52 Week Low
  • ATAI $1.03
  • RWAY $8.35
  • 52 Week High
  • ATAI $4.74
  • RWAY $11.73
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 70.54
  • RWAY 45.44
  • Support Level
  • ATAI $3.60
  • RWAY $10.52
  • Resistance Level
  • ATAI $4.23
  • RWAY $10.77
  • Average True Range (ATR)
  • ATAI 0.33
  • RWAY 0.20
  • MACD
  • ATAI -0.01
  • RWAY -0.05
  • Stochastic Oscillator
  • ATAI 85.09
  • RWAY 25.87

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States.

Share on Social Networks: